Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen [PDF]
Taiwan Journal of Ophthalmology, 2023 PURPOSE: To evaluate the efficacy and safety of 0.1% cyclosporine A cationic emulsion (CsA CE) following prior treatment with 0.05% cyclosporine A anionic emulsion (CsA AE) in moderate to severe dry eye disease (DED).
Yuan-Hsi Chan, Chi-Chin Sun
doaj +3 more sources
Oman Journal of Ophthalmology, 2023 BACKGROUND: Pterygium is very common in India and is usually removed by limbal conjunctival autograft transplantation (LCAT), which, despite being the first-line therapy, is still associated with recurrences of up to 18%.
Usha K Raina +4 more
doaj +3 more sources
Cost utility analysis of cryopreserved amniotic membrane versus topical cyclosporine for the treatment of moderate to severe dry eye syndrome [PDF]
Cost Effectiveness and Resource Allocation, 2020 Background The purpose is to perform a cost effectiveness analysis amniotic membrane vs. topical medications in the use of treating dry eye disease.
Jeffrey Voigt
doaj +2 more sources
Ocular surface and corneal subbasal nerve plexus changes in ocular graft versus host disease patients treated with topical cyclosporine [PDF]
BMC OphthalmologyPurpose To investigate the effect of topical cyclosporine (0.05%) on the ocular surface and corneal sub-basal nerve plexus in patients with chronic Ocular Graft-versus-Host Disease (oGVHD). Methods This prospective study included 24 eyes from 24 patients
Emine Esra Karaca +7 more
doaj +2 more sources
Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation [PDF]
Indian Journal of Ophthalmology, 2021 Purpose: To evaluate the effect of topical cyclosporine 0.05% and osmoprotective lubricating eye drops on patients with dry eye disease (DED) with inflammation as measured by raised tear matrix metalloproteinases (MMP-9).
Ritika Mullick +5 more
doaj +2 more sources
A comparative approach to topical cyclosporine therapy [PDF]
Eye, 1997 Topical cyclosporine has been used by veterinary ophthalmologists since 1989 for the treatment of ocular surface inflammatory disease and keratoconjunctivitis sicca (KCS). As well as ameliorating clinical signs of ocular surface lymphocyte-driven inflammation in the dog, cat and horse, topical cyclosporine significantly raises tear production in both ...
D L Williams, David L Williams
exaly +3 more sources
Comparison of the clinical effects of two different doses (0.05% and 0.1%) of topical cyclosporine A in dry eyes with meibomian gland dysfunction [PDF]
Revista Brasileira de Oftalmologia, 2022 Objective: To compare the clinical efficacy of two different doses of topical cyclosporine A used in addition to artificial tears in the treatment of patients with meibomian dysfunction and secondary dry eye. Methods: Fifty patients aged 18 to 40 years,
Kemal Bayrakceken, Adem Ugurlu
doaj +1 more source
Journal of Clinical Ophthalmology and Research, 2021 Background: Dry Eye Disease (DED) is a multifactorial and complex disease of the ocular surface, with a high prevalence in adults. Aims and Objectives: To compare the efficacy of 2% topical Rebamipide and 0.1% topical Sodium hyaluronate with or without 0.
Priyanka V Gandhi +2 more
doaj +1 more source
Topical Cyclosporin in the Treatment of Dermatologic Diseases [PDF]
International Journal of Immunopathology and Pharmacology, 2002 In spite of the drug's toxicity, cyclosporine A (CsA) is largely used in several diseases, including dermatological pathologies, with beneficial results. In dermatology cyclosporin-A reduces the severity of psoriasis symptoms, Bechet's disease, pyoderma gangrenosum, blistering disorders, aftous stomatitis, lichen planus, atopic dermatitis, alopecia and
FELICIANI, Claudio, A. Tulli
openaire +4 more sources
Journal of Medical Case Reports, 2021 Background Perforation of the cornea is a rare finding in patients with rheumatoid arthritis (RA). Addressing a perforated cornea associated with RA is challenging, since its pathogenesis is not fully elucidated.
Simona Delia Nicoară, Ioana Damian
doaj +1 more source